Effect of multidisciplinary care on diabetic kidney disease: a retrospective cohort study.

Ayano Hayashi, Kayoko Mizuno, Kanna Shinkawa, Kazunori Sakoda, Satomi Yoshida, Masato Takeuchi, Motoko Yanagita, Koji Kawakami
Author Information
  1. Ayano Hayashi: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida-Konoe-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
  2. Kayoko Mizuno: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida-Konoe-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
  3. Kanna Shinkawa: Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  4. Kazunori Sakoda: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida-Konoe-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
  5. Satomi Yoshida: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida-Konoe-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan. yoshida.satomi.4r@kyoto-u.ac.jp.
  6. Masato Takeuchi: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida-Konoe-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
  7. Motoko Yanagita: Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  8. Koji Kawakami: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida-Konoe-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.

Abstract

BACKGROUND: Diabetic kidney disease (DKD) is the most common disease among patients requiring dialysis for the first time in Japan. Multidisciplinary care (MDC) may prevent the progression of kidney failure. However, the effectiveness and timing of MDC to preserve kidney function in patients with DKD is unclear. Therefore, the aim of this study was to investigate whether MDC for patients with DKD affects the preservation of kidney function as well as the timing of MDC in clinical practice.
METHODS: In this retrospective cohort study, we identified patients with type 2 diabetes mellitus and DKD from April 2012 to January 2020 using a nationwide Japanese healthcare record database. The fee code for medical guidance to prevent dialysis in patients with diabetes was used to distinguish between the MDC and non-MDC groups. The primary outcome was a 40% decline in the estimated glomerular filtration rate, and secondary outcomes were death, hospitalization, permanent dialysis, kidney failure with replacement therapy, and emergency temporary catheterization. Propensity score matching was performed, and Kaplan-Meier and multivariable Cox regression analyses were performed.
RESULTS: Overall, 9,804 eligible patients met the inclusion criteria, of whom 5,614 were matched for the main analysis: 1,039 in the MDC group, and 4,575 in the non-MDC group. The primary outcome did not differ between the groups (hazard ratio: 1.18, [95% confidence interval: 0.99-1.41], P = 0.07). The groups also did not differ in terms of the secondary outcomes. Most patients with DKD received their first MDC guidance within 1 month of diagnosis, but most received guidance only once per year.
CONCLUSIONS: Although we could not demonstrate the effectiveness of MDC on kidney function in patients with DKD, we clarified the characteristics of such patients assigned the fee code for medical guidance to prevent dialysis related to diabetes.

Keywords

References

  1. Clin Exp Nephrol. 2019 Apr;23(4):484-492 [PMID: 30341572]
  2. J Diabetes Investig. 2021 Feb;12(2):207-216 [PMID: 32597548]
  3. Nephrol Dial Transplant. 2013 Mar;28(3):671-82 [PMID: 23223224]
  4. Clin J Am Soc Nephrol. 2021 Apr 7;16(4):648-659 [PMID: 33177074]
  5. Front Endocrinol (Lausanne). 2022 Dec 09;13:1079725 [PMID: 36568108]
  6. J Diabetes. 2018 Jul;10(7):572-580 [PMID: 29154443]
  7. J Nephrol. 2015 Jun;28(3):329-38 [PMID: 25249468]
  8. Clin J Am Soc Nephrol. 2011 Apr;6(4):704-10 [PMID: 21273376]
  9. Clin Epidemiol. 2020 Apr 08;12:367-375 [PMID: 32308492]
  10. Clin Rheumatol. 2022 Feb;41(2):541-548 [PMID: 34505212]
  11. Clin Exp Nephrol. 2019 Apr;23(4):493-500 [PMID: 30341571]
  12. Diabetes Obes Metab. 2022 Mar;24(3):486-498 [PMID: 34779098]
  13. Kidney Int. 2014 Mar;85(3):686-92 [PMID: 24067435]
  14. BMJ Open. 2020 Dec 29;10(12):e041149 [PMID: 33376170]
  15. Mayo Clin Proc. 2020 Feb;95(2):265-273 [PMID: 32029085]
  16. Kidney Int. 2017 Aug;92(2):297-305 [PMID: 28709600]
  17. Clin Exp Nephrol. 2019 Aug;23(8):1031-1038 [PMID: 31030309]
  18. J Diabetes Complications. 2018 May;32(5):474-479 [PMID: 29526625]
  19. Nephrol Dial Transplant. 2023 Jan 23;38(1):158-166 [PMID: 35195257]
  20. Intern Med. 2021 Jul 1;60(13):2017-2026 [PMID: 33518556]
  21. Eur J Endocrinol. 2021 Jan;184(1):E1-E4 [PMID: 33112276]
  22. PLoS One. 2022 Oct 14;17(10):e0266617 [PMID: 36240220]
  23. Am J Epidemiol. 2019 Jan 1;188(1):250-257 [PMID: 30189042]
  24. Lancet. 2020 Feb 29;395(10225):709-733 [PMID: 32061315]
  25. PLoS One. 2018 Jun 1;13(6):e0198387 [PMID: 29856821]
  26. Kidney Int. 2020 Oct;98(4S):S1-S115 [PMID: 32998798]
  27. BMC Nephrol. 2015 Oct 12;16:161 [PMID: 26458811]
  28. Clin Exp Nephrol. 2021 Feb;25(2):166-172 [PMID: 33040245]
  29. Am J Kidney Dis. 2009 Jun;53(6):982-92 [PMID: 19339088]
  30. J Clin Med. 2021 Jun 30;10(13): [PMID: 34209083]
  31. Am J Med. 2015 Jan;128(1):68-76 [PMID: 25149427]
  32. Nephrology (Carlton). 2010 Jun;15 Suppl 2:31-6 [PMID: 20586945]

MeSH Term

Humans
Diabetes Mellitus, Type 2
Renal Dialysis
Diabetic Nephropathies
Retrospective Studies
Renal Insufficiency

Word Cloud

Created with Highcharts 10.0.0patientskidneyMDCDKDdialysisstudyguidancediseasecarepreventfunctioncohortdiabetesgroupsDiabeticfirstMultidisciplinaryfailureeffectivenesstimingretrospectivefeecodemedicalnon-MDCprimaryoutcomesecondaryoutcomesperformed1groupdifferreceivedBACKGROUND:commonamongrequiringtimeJapanmayprogressionHoweverpreserveunclearThereforeaiminvestigatewhetheraffectspreservationwellclinicalpracticeMETHODS:identifiedtype2mellitusApril2012January2020usingnationwideJapanesehealthcarerecorddatabaseuseddistinguish40%declineestimatedglomerularfiltrationratedeathhospitalizationpermanentreplacementtherapyemergencytemporarycatheterizationPropensityscorematchingKaplan-MeiermultivariableCoxregressionanalysesRESULTS:Overall9804eligiblemetinclusioncriteria5614matchedmainanalysis:0394575hazardratio:18[95%confidenceinterval:099-141]P = 007alsotermswithin1 monthdiagnosisperyearCONCLUSIONS:AlthoughdemonstrateclarifiedcharacteristicsassignedrelatedEffectmultidisciplinarydiabeticdisease:Retrospective

Similar Articles

Cited By